Resolution Bioscience
Paul Stull is a seasoned scientist with extensive experience in molecular diagnostics, biotechnology, and research management. Currently serving as a Senior Scientist at Resolution Bioscience since 2018, Paul focuses on the development of NGS-based companion diagnostics for FDA PMA, encompassing library preparation and data analysis for cancer applications. Previously, Paul held positions including Senior Staff Scientist at Beckman Coulter, where technical strategy for molecular R&D assay development programs was a key focus, and Principal Investigator at DuPont, leading impactful applied research. Earlier roles include Director of Chemistry at Genicon Sciences, where R&D and IP strategy were managed, and Staff Scientist at Hologic, contributing significantly to the development of FDA-approved molecular diagnostic assays. Paul holds a Postdoctoral degree in Organic Chemistry from Emory University and a PhD from the University of South Florida.
Resolution Bioscience
Resolution Bioscience, a part of Agilent, is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy.